30APR10 DS product portfolio

合集下载

Blue Coat Systems PacketShaper 11.6 第三方版权声明说明书

IPv6 Classification
PacketShaper 11.6
Third Party Copyright Notices
© 2016 Blue Coat Systems, Inc. All rights reserved. BLUE COAT, PROXYSG, PACKETSHAPER, CACHEFLOW, INTELLIGENCECENTER, CACHEOS, CACHEPULSE, CROSSBEAM, K9, DRTR, MACH5, PACKETWISE, POLICYCENTER, PROXYAV, PROXYCLIENT, SGOS, WEBPULSE, SOLERA NETWORKS, DEEPSEE, DS APPLIANCE, SEE EVERYTHING. KNOW EVERYTHING., SECURITY EMPOWERS BUSINESS, BLUETOUCH, the Blue Coat shield, K9, and Solera Networks logos and other Blue Coat logos are registered trademarks or trademarks of Blue Coat Systems, Inc. or its affiliates in the U.S. and certain other countries. This list may not be complete, and the absence of a trademark from this list does not mean it is not a trademark of Blue Coat or that Blue Coat has stopped using the trademark. All other trademarks mentioned in this document owned by third parties are the property of their respective owners. This document is for informational purposes only. BLUE COAT MAKES NO WARRANTIES, EXPRESS, IMPLIED, OR STATUTORY, AS TO THE INFORMATION IN THIS DOCUMENT. BLUE COAT PRODUCTS, TECHNICAL SERVICES, AND ANY OTHER TECHNICAL DATA REFERENCED IN THIS DOCUMENT ARE SUBJECT TO U.S. EXPORT CONTROL AND SANCTIONS LAWS, REGULATIONS AND REQUIREMENTS, AND MAY BE SUBJECT TO EXPORT OR IMPORT REGULATIONS IN OTHER COUNTRIES. YOU AGREE TO COMPLY STRICTLY WITH THESE LAWS, REGULATIONS AND REQUIREMENTS, AND ACKNOWLEDGE THAT YOU HAVE THE RESPONSIBILITY TO OBTAIN ANY LICENSES, PERMITS OR OTHER APPROVALS THAT MAY BE REQUIRED IN ORDER TO EXPORT, RE-EXPORT, TRANSFER IN COUNTRY OR IMPORT AFTER DELIVERY TO YOU. Americas: Blue Coat Systems, Inc. 384 Santa Trinita Avenue Sunnyvale, CA 94085

有关钱的单词100个

有关钱的单词100个1. Money - 钱2. Cash - 现金3. Currency - 货币4. Banknote - 钞票5. Coin - 硬币6. Wallet - 钱包7. Credit card - 信用卡8. Debit card - 借记卡9. Bank account - 银行账户10. Savings - 储蓄11. Checking account - 支票账户12. ATM - 自动取款机13. Withdrawal - 取款14. Deposit - 存款15. Transaction - 交易16. Interest rate - 利率17. Loan - 贷款18. Mortgage - 抵押贷款19. Investment - 投资20. Budget - 预算21. Bill - 账单22. Income - 收入23. Expense - 开支24. Balance - 余额25. Profit - 利润26. Loss - 损失27. Salary - 工资28. Tax - 税29. Inflation - 通货膨胀30. Exchange rate - 汇率31. Financial - 金融的32. Wealth - 财富33. Poverty - 贫困34. Prosperity - 繁荣35. Donation - 捐赠36. Fees - 费用37. Interest - 利息38. Insurance - 保险39. Retirement - 退休40. Stock - 股票41. Dividend - 股息42. Entrepreneur - 企业家43. Inheritance - 遗产44. Overdraft - 透支45. Remittance - 汇款46. Diversification - 多元化47. Capital - 资本48. Venture - 冒险49. Exchange - 交换50. Bull market - 牛市51. Bear market - 熊市52. Stock market - 股市53. Bond - 债券54. Mutual fund - 共同基金55. Real estate - 房地产56. Economic - 经济的57. Invoice - 发票58. Entrepreneurship - 创业59. Deductible - 免赔额60. Transaction fee - 交易费61. Budgeting - 预算编制62. Foreign exchange - 外汇63. Counterfeit - 伪造的64. Financial advisor - 财务顾问65. Fiscal - 财政的66. Utility bill - 水电费账单67. Principal - 本金68. Interest payment - 利息支付69. Economic growth - 经济增长70. Payroll - 工资单71. Gross income - 总收入72. Net worth - 净资产73. Credit score - 信用评分74. Collateral - 抵押品75. Bankruptcy - 破产76. Development - 开发77. Recession - 经济衰退78. Indebted - 负债的79. Investment portfolio - 投资组合80. Financial statement - 财务报表81. Refund - 退款82. Coupon - 优惠券83. Invoice - 发票84. Entrepreneurship - 创业85. Deductible - 免赔额86. Money order - 汇票87. Payment - 付款88. Prosperity - 繁荣89. Cryptocurrency - 加密货币90. Economic indicator - 经济指标91. Annual percentage rate (APR) - 年利率92. Capital gains - 资本利得93. Recession - 经济衰退94. Unemployment - 失业95. Savings account - 储蓄账户96. Loan repayment - 贷款还款97. Asset - 资产98. Liability - 负债99. Bearish - 看空的100. Portfolio - 投资组合。

Repower5MW 风机[1]

5 MW
• 叶轮直径 Rotor diameter:126 m
• 轮毂高度 Hub heights:
•陆上型 Onshore: 120 m
•离岸型 Offshore: 85 – 100 m
世界上最大的叶片—LM61.5
世界上最大的风机
世界上最大的风机
5MW样机的组装 Assembly of the 5M Prototype
0 0
测量结果 Measurements
Guaranteed and Measured Power Curves REpower 5M
REpower 5M功率曲线保证值和测量值的比较
比预测值高1-3%
5
guaranteed el. Power (kW)
10
15
wind speed at hub height (m/s)
指
标
99%
98% 98% 98%
98%
97%
96%
95%
80
85%
2005年2月以来，平均 95.3%
70 Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan
Month
月份
%
el. Power (kW) - medium voltage path
6000 5000 4000 3000 2000 1000
¾ 冗余设计及更加完善的安全保障 Designed with redundancies and extended safety factors
¾ 结合法兰的模块化传动系统 Modular drive train with flanges
¾ 主轴双轴承设计 Double bearing of main shaft

雀巢收购惠氏

Analysis of Nestle-Wyeth Acquisition Deal浅析雀巢—惠氏收购案国贸093 柳飘然 2009014315内容简介：2012年4月23日，“并购狂人”雀巢上演生命中最辉煌的一刻：以118.5亿美元收购了婴幼儿奶粉品牌——惠氏（即辉瑞旗下的营养品业务)！业界评价称，此宗收购案成为今年迄今为止最大规模的交易之一。

收购后的雀巢有望一跃成为中国最大的婴儿奶粉供应商，可以在有利可图的婴儿配方奶市场抢占先机，并将对中国婴儿奶粉行业产生重要影响。

关键词：收购acquisition，雀巢Nestle，惠氏Wyeth，婴儿配方奶粉市场baby milk formula market Switzerland-based Nestle, the world’s largest food giant, agreed on 23 Apr 2012 to acquire Wyeth baby formula business from Pfizer, the world’s largest drug manufacturer, in a deal of 11.85 billion U.S. dollars. As a strategic move to enhance the company’s status in the global field of infant nutrition business. The acquisition means that Nestl e wins the bid and it can forestall the lucrative infant formula market now.1 The Introduction of the Two Parties1.1A brief introduction to NestleNestle is the world’s leading nutrition, health and wellness company. Nestl e with headquarters in Vevey, Switzerland. It was founded in 1866 by Henri Nestle. And it means “Little Birds Nest”,standing for love, security, natural and nutrition. Their mission of "Good Food, Good Life" is to provide consumers with the best tasting, most nutritious choices in a wide range of food and beverage categories and eating occasions, from morning to night. Their brands are : Bottled water, Baby foods, Chocolate , Coffee, Dairy, Drinks, Ice cream and so on.The company is based on sound human values and principles. The Nestle Corporate Business Principles are at the basis of their company’s culture, developed over 140 years, wh ich reflects the ideas of fairness, honesty and long-term thinking. They employ around 328 000 people and have factories or operations in almost every country in the world. Nestle sales for 2011 were almost CHF 83.7 bn.1.2 A brief introduction to WyethWyeth, formerly one of the companies owned by American Home Products Corporation (AHP), was a pharmaceutical company. The company was based in Madison, New Jersey, USA. On January 25,2009 .The Wall Street Journal reported that Pfizer agreed to buy Wyeth at a cost of US$68 billion. a deal financed with cash, shares and loans. The deal was completed on October 15, 2009.Hence Wyeth is part of Pfizer.Pfizer Inc: Evolving to meet the needs of a changing society. Since Pfizer was founded by cousins Charles Pfizer and Charles Erhart in 1849, their pharmaceutical company has remained dedicated to discovering and developing new, and better, ways to prevent and treat disease and improve health and well being for people around the world.2 The Reasons for the Acquisition2.1 The Reasons for Nestle◆To maximize market share in Asia-pacificThe last few years, Europe and the United States and other countries infant food market becomes saturated, and the prospects for development in the Asia-Pacific market and plenty of room, especially the Asia-Pacific region the number of infants and young children most market growth prospects. The smaller Wyeth, with 60 percent of its sales are in emerging markets (Asia-Pacific), many of them with large, fast-growing populations..Wyeth's business in Asia as key since the region accounts for 45 percent of the world milk formula market -- China alone accounts for a fifth of global sales .In a strategic move to enhance its position in Asia-Pacific infant nutrition ,the purchase will greatly expand Nestle's presence in the middle- to high-end formula market in Asia-pacific.◆To enhance their infant nutrition businessWyeth Nutrition is a dynamic, high-quality infant nutrition business that complements Nestle’s existing portfolio with strong brands in key segments and geographies. It is reported that in emerging markets, more and more womencontinue to work after giving birth, this trend is particularly evident in China. This is the annual output value of $ 30 billion, 10 percent of the annual growth rate of the baby food industry is a great impetus.It will enhance their infant nutrition business, building on their growth-focused strategy, global presence and pioneering research and development. They will be able to combine well-known brands like S-26 Gold, SMA and Promil with their existing portfolio of trusted and successful brands such as Nan, Gerber, Lactogen, Nestogen and Cerelac infant cereal.2.2 The Reasons for Wyeth◆To divest the milk business ——Wyeth's businessPfizer decided to divest its milk business to strip non-main business and concentrate on new drug research on July, 2011. This is the company's largest capital divestiture since 2006. Wyeth might be able to acquire a bigger and better customer base, or strengthen their management team. Not only does it increase turnover but it also makes economies of scale possible, thus giving companies a competitive advantage in local markets.3 The Impacts of the Acquisition3.1 The direct impacts on the two parties◆Making Nestle the largest formula provider in China.The acquisition of Pfizer's Wyeth milk powder is likely to make Nestle the largest formula provider in China. According to a CI Consulting analysis, Dumex held the largest proportion of China's formula market by July 2010, taking up 16.7 percent of it. Following the company was Mead Johnson, with 12 percent of the market, and Nestle, with 10.5 percent. In the fourth position was Abbott Laboratories, which had 7.2 percent of the market, and Wyeth, with 4.7 percent of the market, was in the fifth position.So it is a possibility for Nestle to become the largest formula provider in China.◆Increasing sales of infant formulaThe purchase will lead to annual cost benefits of $160 million and will boost earnings per share in the first full year, Nestle Chief Executive Officer Paul Bulc ke said on a conference call. The Pfizer unit will increase Nestle’s sales of infant formula to $7 billion a year from $5 billion. Euro monitor figures predict that 45 percent of the growth in the market for infant nutrition products will come from China in the next five years. The country was the source of roughlya third of the $2.1 billion in sales the Pfizer unit had in 2011.◆Causing external staff redeploymentIt is not yet known what impact the sale will have on employment at the plant in the future. However, Pfizer said all employees currently involved in the nutrition business will be transferred to Nestle, with consultations to take place where required. All of the Pfizer employees working in the unit will be transferred to Nestlé when the deal completes in the first half of 2013, subject to union consultation. Pfizer also determined Nestle was a safer home for its employees, added another person familiar with the matter.3.2 The expected impacts on Chinese baby milk formula market◆H aving a greater say for foreign brands in Chinese marketThe acquisition is also expected to improve the company's dairy production lines and give it more say in pricing. Foreign brands of milk formula, faced with greater competition, are likely to become more powerful about pricing their products.◆Causing infant formulas Quality RisesDomestic companies, meanwhile, are likely to come under greater pressure as their foreign rivals become stronger. Chinese brands must insist on perfect quality and no shortcuts. The baby formula scandles of the past has convinced 90% of all mothers that the western brands are safer. Domestic companies have to through raising the product quality and quality economic , the brand advantage of the company’s products is guarante ed , in order to occupy a tiny space in the fierce market competitionTo sum up，this acquisition underlines Nestle’s commitment to be the world’s leading nutrition, health and wellness company. Wyeth’s strong brands and product portfolio, its talented people dedicated to the success of its business, together with its geographic presence - 85% of its sales are in emerging markets - will complement their existing infant nutrition business perfectly. The combined entities will enable Nestle to deepen their engagement with consumers, offering them a wider choice of nutritious food to ensure their children make a healthy start to a healthy life.(Total: 1464 words)Reference(1)China Daily “Nestle's acquisition to alter baby-food market” ( Update April 25,2012) [Online] Available at:/business/2012-04/25/content_25231403.htm[Accessed May 7, 2012](2)CCTV news content “China-Wyeth/Nestle/Acquisition ”( Update May 7, 2012) [Online] Available at:/news.jsp?fileId=139265 [Accessed May 7, 2012](3)REUTERS “EXCLUSIVE-Nestle, Danone early leaders to land $10 bln Wyeth” (Update August18, 2011) [Online] Available at:/article/companyNews/idUKL5E7JI2K320110818?symbol=ABT[Accessed May 7, 2012](4)China economic review ( Update August 9, 2011) [Online] Available at:/content/nestle-rumored-be-preparing-acquisition-pfizer%E2%80%99s-baby-n utrition-unit [Accessed May 7, 2012](5)Nestle home page ( Update May 7, 2012) [Online] Available at:/AboutUs/Pages/AboutUs.aspx [Accessed May 7, 2012](6)Pfizer home page ( Update May 8, 2012) [Online] Available at:/welcome/ [Accessed May 8, 2012]。

飞利浦光源介绍

飞利浦光源介绍许晓景 OEM技术支持照明光源固体发光光源白炽灯 (热辐射光源) 场致发光灯真空灯充气灯卤钨灯充气灯泡荧光灯电光源半导体发光灯LED 低气压灯弧光放电灯紧凑型荧光灯 QL灯低压钠灯气体放电发光光源高压汞灯高气压灯霓虹灯氖灯高压钠灯金卤灯高压氙灯碳弧灯其他2辉光放电灯表示灯泡光电性能的主要技术参数Main parameters of lamp • • • • • • • 功率(power) 瓦 (W) 光通量(Lumen output) 流明 (lm) 色温(color temp.) 开 (K) 显色指数(color rendering) Ra 寿命aver. Life) 小时 (h) 发光效率(efficiency) 流明/瓦(lm/W) 光通维持率 maintenance %3飞利浦荧光灯介绍及其创新内容简介• TL荧光灯介绍– T5荧光灯介绍及趋势 • 紧凑型荧光灯介绍– 一体化紧凑型荧光灯 – 分离式紧凑型荧光灯• 总结5飞利浦荧光灯产品线结构LAMPS GLS Halogen环管TLCFL直管HIDTLETLE 54T5Master T5 HE Master T5 HO ES T5 Mini T5 TLD std C2S TLD reflexT8TLD super 80 TLD secura TLD 90 delux6管径的比较T12 T8 T57T5 光源及其应用趋势简介应用趋势应用主要趋势 • 更自由的应用场所 • 间接照明 • 小型化设计 • 节能化设计 • 重视光线质量 • 优化替换（超长寿命减少替换） • 光色由黄光向白光转换（4000K)• 可调光（亮度，光色） • 高流明输出9TL5 特点16mm 直径，适应更小设计 HE (14, 21, 28, 35W) & HO (24, 39, 49, 54, 80W) 冷室技术，使最高光效达 104lm/W 低汞 (1.4 or 3.0mg)，更加环保三基色涂粉(/80 and /90 colors) 平均寿命24k 小时只适用电子整流器不同的灯脚 (G5 instead of G13)10BENEFITS TL5改进的光学表现带来新的设计可能小型化：16mm直径带来更紧凑更舒适的照明成本降低: 长寿命 (24k hours) 以及几乎持久的光输出更高的灯具效率 (TL-D: 25oC) 节能达到 40% 环保: 只有3mg含汞量需要更小的空间和更少的包装材料11环境温度对灯管性能的影响（冷室技术）Relative values % → 140 T8 T5 100602020 30 40 50Tambient (draught-free air) °C →12BENEFITS TL5ALMOST CONSTANT LIGHT OUTPUTLumen in % → 100 90 80 70 60 50 0 4000 8000 12000 16000 2000090Burning hours →Almost constant light output during entire lifespan Max. decrease of 10%13飞利浦紧凑型节能灯介绍飞利浦紧凑型荧光灯产品线结构LAMPS GLS Halogen民用CFLTL专业HIDCFL-IEssential Ambiance Genie TornadoCFL-IMaster SLE Master PLEU PL-S PL-C PL-L PL-TCFL-NIPL-LJ PL-F PL-H PL-QMaster EcoHLDecoTwist15一体化紧凑型荧光灯专业产品系列适应各种环境 Í 汞齐技术超常寿命达10,000 小时节电 80% 宽电压设计:170-250V 符合 IEC标准• • •低业主总成本寿命从 8,000 小时提高到 10,000 小时运用汞齐技术– 更佳流明维持率 – 适应各种环境温度 (室内&室外)17什么使得Master CFL-I从同类产品中脱颖而出?1. 在同类中有最佳的温度性能– 汞齐技术的应用保证在不同应用场合都能达到高流明输出2. 最优化的总体成本– – 长的寿命和高的光通维持率:减低了需要置换灯的成本可靠的工作使批量置换变为可能18汞齐技术应用于MASTER规格• 稳定的光输出– 应用于室内&室外 – 在相同的照度级别下需要的灯数量更少 – 较低的汞含量• 更好的光通维持率19MASTER PLEU• • • • 低业主使用总成本 10,000寿命汞齐技术高光效20MASTER SLE(D)•防眩光外罩•低业主使用总成本•10,000寿命•汞齐技术•高光效Ecotone2005（大功率一体化节能灯）: 10,000 小时民用产品系列替代灯泡ÍGenie, Ambiance长寿(确保使用三年)节电达80%宽幅电压设计: 170-250V符合IEC标准Essential•Mature product in CFL portfolio, cash cow •No new product development, focus on quality •Cost drive in purchasing•Defend market share, lower price if needed特点•高性价比•三年使用寿命•适用民用应用场所Strategy•Product in growth phase, as is market growth => Star •Controlled price reduction to take over Essential•Technical development: increase quality levels, make all versions available to all NLO ’s •Grow market share, price premium over EssentialGenie•最小的外形•三年使用寿命(6,000hrs) •理想的灯泡替代产品Strategy•New product launch in HV APR (early & rapid growth)•High market growth expected, share still relatively low (qualification: question mark) => grow share •Upgrade in portfolio, priced at premium from high Wattage Essentials 18W & 23W •Innovation medium term: smaller size (T2 burner)Tornado•紧凑外形，高流明输出•装饰性“螺旋形”外形新增加产品系列DecoTwist•直接安装•T5分离式紧凑型荧光灯PL-LPL-C600 -1800 lmRedesignedPL-T飞利浦T5C产品线分布及流明输出PL -接桥技术的影响PL-C Master 特性接桥位置的优化:•实际使用中光通量提高了6%•提高了系统的温度特性先进的飞利浦保护膜技术:•灯的寿命从8000提高到了10000小时•光通维持率得到提高，保证寿命期间稳定光通输出•同样的投入，12％的额外光通2 -4 mm 4 -8 mm比竞争对手多了18%的光通PL-S rangeRange E cotoneProduct type P L-SU SP B ridge technologyBenefits- Low cost of ownership- Long life (8,000 hours)Application E mergency lighting, consumerluminairs, downlightingTarget market P rofessional end users, hospitalityW hy in portfolio ?Replacement product, stablemarket. OE M opportunitiesCompetition OsramPL-C rangeRange E cotoneProduct type P L-C MASTERU SP B ridge technologyBenefits- Higher Lumen output- Low cost of ownership- Long life (10,000 hours)Application DownlightingTarget market P rofessional end users, hospitalityW hy in portfolio ?Unique features in fast growingdown-lighting segmentCompetition Osram Dulux, GE B iaxPL-L rangeRange E cotoneProduct type P L-L MASTERU SP B ridge technologyBenefits- Higher Lumen output- Low cost of ownership- Long life (12,000 hours)Application Office (TL) luminaires, recessedTarget market P rofessional end users, hospitalityW hy in portfolio ?High Lumen, compact alternativefor TL applications (T5!)Competition Osram Dulux, GE B iaxPL-T rangeRange E cotoneProduct type P L-TU SP Amalgam technologyBenefits- S table Lumen output- Low cost of ownership- Long life (15,000 hours)Application E mergency lighting, downlightingTarget market P rofessional end users, hospitalityW hy in portfolio ?Offers high Lumen options in downlightersCompetition Osram Dulux T, GE B iax Q灯管设计改变(由弯管变为直管-使用冷端技术-瓦数增大到-更小灯座新PL-T的优势优势:全新设计•对称的外形•小灯脚•小的尺寸•可以替代所有竞争者的类型优势PL-T 42wStandard 42wPLTSelect the right lamp for the best performance of your lighting installation.MASTER PL-TMASTER PL-T (with Cold Spot technology)Select the right lamp for the best performance of your lighting installation.Marketing & Business Development Light PJL Confidential60W 4000 lm/830 and /84085W 6000 lm120W 9000 lmMaster PL-H rangePL-H luminairesPL-Q Pro配合灯具适合走廊，厕所，电梯间，接待处等场所照明灯脚: 2GX13管径: 16mm(比TLE管径细55%）使用电子整流器22W40W55W60WT5C产品规格TL5C。

MTU ONSITE ENERGY

© MTU Onsite Energy GmbH All rights reserved
01. OUR VISION AND STRATEGY
Vision
We at Tognum set the standard as the preferred partner for the best solutions in power and propulsion.
LuftfahrzeugMotorenbau GmbH
L’Orange
DaimlerChryslerOff-Highway
Tognum „Home of Power Brands”
100 years MTU
MTU Friedrichshafen
Independent Group
IPO
MTU Onsite Energy
S 4000 S 2000 S 1600
450 750 1,000 2,000 3,000
Series 1600 Utilisation of MTU engines
Strategy
Maintaining leadership in product innovation. Broadening application and customer portfolio. Custom-made products. Integrating system and service offerings.
06. PRODUCT PORTFOLIO
AN EXCELLENT PRODUCT RANGE COVERAGE
Series 4000
Utilisation of MTU engines and third parties´ engines

美国联合保健公司产品说明书：测试生成产品

UnitedHealthcare PharmacyClinical Pharmacy ProgramsProgram Number 2023 P 2018-16Program Prior Authorization/Medical Necessity – TestosteroneMedication Androderm, Androgel*, Fortesta*, Jatenzo*, Natesto*, Kyzatrex*,Testim, testosterone topical solution (generic Axiron)*, testosteronetransdermal gel (generic Testim)*, Tlando*, Vogelxo*, Xyosted*P&T Approval Date 2/2014, 4/2014, 5/2014, 7/2014, 10/2014, 10/2015, 5/2016, 6/2017,6/2018, 2/2019, 6/2019, 7/2020, 8/2021, 9/2022, 1/2023Effective Date 4/1/2023;Oxford only: 4/1/20231.Background:Testosterone products are approved by the Food and Drug Administration (FDA) for testosterone replacement therapy in males with primary hypogonadism (congenital or acquired) orhypogonadotropic hypogonadism (congenital or acquired). Primary hypogonadism originatesfrom a deficiency or disorder in the testicles. Secondary hypogonadism indicates a problem in the hypothalamus or the pituitary gland. Testosterone use has been strongly linked to improvements in muscle mass, bone density, and libido.The purpose of this program is to provide coverage for androgens and anabolic steroid therapy for the treatment of conditions for which they have shown to be effective and are within the scope of the plan’s pharmacy benefit. Coverage for the enhancement of athletic performance or bodybuilding will not be provided.a3.Additional Clinical Rules:•Notwithstanding Coverage Criteria, UnitedHealthcare may approve initial and re-authorization based solely on previous claim/medication history, diagnosis codes (ICD-10)and/or claim logic. Use of automated approval and re-approval processes varies by programand/or therapeutic class.•Supply limits may be in place.•* May be excluded from coverage•+ Coverage for patient population may be dependent upon benefit design4.References:1.AACE Hypogonadism Task Force. American Association of Clinical EndocrinologistsMedical Guidelines for Clinical Practice for the Evaluation and Treatment ofHypogonadism in Adult Male Patients – 2002 Update. Endocr Pract. 2002; 8(No. 6): 439-456.2.The World Professional Association for Transgender Health (WPATH), Standards of Carefor the Health of Transsexual, Transgender, and Gender Nonconforming People, 7thVersion.3.Cook, David M, et al. "American Association of Clinical Endocrinologists medicalguidelines for clinical practice for growth hormone use in growth hormone-deficient adultsand transition patients - 2009 update: executive summary of recommendations." Endocrinepractice 15.6 (2009):580-586.4.Gibney, James, et al. "Growth hormone and testosterone interact positively to enhanceprotein and energy metabolism in hypopituitary men." American journal of physiology:endocrinology and metabolism 289.2 (2005):E266-E2715.Bhasin, S, et al. "Testosterone replacement and resistance exercise in HIV-infected menwith weight loss and low testosterone levels." JAMA. 2000. 283.(6) 763-770.6.Isidori, Andrea M, et al. Effects of testosterone on sexual function in men: results of ameta-analysis. Clinical endocrinology. 2005 63(4):381-394.7.Kenny, A M, et al. Effects of transdermal testosterone on bone and muscle in older menwith low bioavailable testosterone levels. The journals of gerontology. 2001. 56(5) M266-M272.8.Tracz, Michal J, et al. Testosterone use in men and its effects on bone health. A systematicreview and meta-analysis of randomized placebo-controlled trials. The Journal of clinicalendocrinology and metabolism. 2006. 91(6):2011-2016.9.Bolona, Enrique R, et al. Testosterone use in men with sexual dysfunction: a systematicreview and meta-analysis of randomized placebo-controlled trials. Mayo Clinicproceedings.2007. 82(1):20-28.10.Androderm [package insert]. Madison, NJ: Allergan, Inc; May 2020.11.Androgel [package insert]. North Chicago, IL: AbbVie Inc; May 2020.12.Fortesta [package insert]. Malvern, PA: Endo Pharmaceuticals Inc; January 2022.13.Testim [package insert]. Malvern, PA: Endo Pharmaceuticals Inc; August 2021.14.Natesto [package insert]. Mississauga, ON: Acerus Pharmaceuticals Corporation;December 2021.15.Vogelxo [package insert]. Maple Grove, MN: Upsher-Smith Laboratories, LLC; April2020.16.Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab 2017; 102:3869.17.The Endocrine Society. Testosterone therapy in Adult Men with Androgen DeficiencySyndromes. J Clin Endocrinol Metab, May 2018, 103(5):1–30.18.Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline.American Urological Association Education and Research, Inc 2018.19.Xyosted [package insert]. Ewing, NJ: Antares Pharma, Inc; November 2019.20.Jatenzo [package insert]. Northbrook, IL: Clarus Therapeutics, Inc; March 2019.21.Tlando [package insert]. Ewing, NJ: Antares Pharma, Inc; March 2022.22.Kyzatrex [package insert]. Raleigh, NC: Marius Pharmaceuticals LLC; September 2022.Program Prior Authorization/Medical Necessity - TestosteroneChange ControlDate Change2/2014 Create Prior Authorization Criteria4/2014 Revised Reauthorization Criteria; formatting corrections, referencesupdated.5/2014 Revised the initial authorization criteria to include subsections for themale population and the female to male transsexual population, updatedto include language from the gender identity disorder/ gender dysphoriatreatment medical coverage determination guideline, referencesupdated7/2014 Added Natesto and Vogelxo to criteria. Changed coverage criteria fromspecific product names to topical testosterone products.10/2014 Modified criteria for total testosterone to consider reference range of thelaboratory. Added criteria for when Free Testosterone level may beutilized. Added criteria for conditions that do not require testosteronelevels. Extended initial authorization period for patients already ontherapy.12/2014 Testosterone free level units corrected.10/2015 Clarified initial authorization periods. Clarified that levels forreauthorization should be within the past 6 months for patients new totestosterone and within the past 12 months for continuing users.Updated references.5/2016 Removed age requirement from female to male transsexual coveragerequirements. Updated gender identity disorder to gender dysphoria.6/2017 Updated criteria for Gender Dysphoria. Updated reauthorizationcriteria to clarify that new to therapy refers to use of less than one yearand continuing therapy refers to use of one year or longer.6/2018 Updated required testosterone level to less than 300 ng/dL based on2018 American Urological Society treatment guidelines.2/2019 Program name change from Topical Androgens to Testosterone.Xyosted added to program.6/2019 Jatenzo added to program.7/2020 Updated initial authorization to 6 months for both new and existingusers. Added state mandate language. Updated references.8/2021 Annual review. Updated references. Removed Striant as it is no longeron the market.9/2022 Tlando added to program. Removed brand Axiron from program sinceit is no longer available. Updated to note generic Testim is typicallyexcluded. Updated references.1/2023 Kyzatrex added to program. Increased initial authorization to 12months and changed reauthorization to require a lab value within thepast 12 months.。

D1-心脏生理解剖结构和传导路径ppt课件

bster EP Training 2003 y, Conduction System, Positions
BW产品综述
Slide 1
7/6/2024
电生理培训（一）
心脏解剖结构、电传导路径导管定位
bster EP Training 2003 y, Conduction System, Positions
Positions
冠状窦心尖
Slide 38
7/6/2024
电生理检查
心内心电图前传测试
前传
从高位右房起搏
逆传
bster EP Training 2003 y, Conduction System, Positions
从右室心尖起搏
Slide 39
7/6/2024
Slide 4
7/6/2024
左室上腔静脉主动脉弓左上肺静脉左下肺静脉
右房下腔静脉
右室
bster EP Training 2003 y, Conduction System, Positions
Slide 5
7/6/2024
主动脉
房间隔
卵圆窝
bster EP Training 2003 y, Conduction System, Positions
bster EP Training 2003 y, Conduction System, Positions
P wave - Atrial Depolarisation
QRS - Ventricular Depolarisation
PR interval - time taken for the impulse to be conducted from the SA node to the Purkinjie

新一代降糖药gosogliptin

.
2012 THOMSON REUTERS. For more information go to /copyright/
.
2007, and the study was expected to complete in June 2008 [ 868416]. In June 2009, data from the trial were presented at the 69th ADA scientific sessions in New Orleans, LA. A total of 289 patients were treated with 20 or 30 mg of gosogliptin qd or placebo. At week 12, both doses significantly reduced HbA1c compared with placebo, with 55.8 and 52.2% of patients in the 20 and 30 mg dose groups, respectively, achieving HbA1c less than 7% compared with only 23.8% of the placebo group. The drug was well tolerated with the most common adverse events being pain in extremity, pharyngolaryngeal pain, headache and dyspepsia [1013516 ].
Target
Dipeptidyl peptidase IV
Update date
17-JUL-2012
Reason for update

三星和博世SBL动力电池介绍

- Pack Development (Stuttgart) - Sales & Marketing (Stuttgart)
- Pack Development (Orion, MI) - Pack Manufacturing (Springboro, OH)
Page 3
Foton & SB LiMotive Meeting
Page 10
Foton & SB LiMotive Meeting
④ Cost Competitiveness Experience from IT Battery Business
Last 10 years, as energy density doubled and sales volume increased
96
CAGR=28%
65
73
Tianjin
Cheonan
34 22 38
54
Shanghai
Dongguan
2005 2006 2007 2008 2009 2010
Polymer
2011
Cylindrical
Prismatic
Tianjin
Page 9
Foton & SB LiMotive Meeting
[ Inauguration Ceremony in Nov. 2010 ]
Page 4
Foton & SB LiMotive Meeting
Ulsan Plant
Complex for Suppliers SDI New Factory
Total Campus : 2,300,000 sqm
SBL Space : 13,000 sqm (Floor Space : 40,000 sqm) - Future Space : 50,000 sqm Construction Period : 9 Months (Sep. 2009 ~ May. 2010)

香港金融专业各大学金融录取分数线与排名

香港金融专业各大学金融录取分数线与排名作为亚洲高等教育领先的香港，不仅引起林立的高校和一流的教育制度，吸引来自全球各地学生赴港留学。

这其中也包括了大量的内地学生。

硕士去香港留学一直被认为“性价比”很高的选择，离家近，文化近，学制短，花钱少，不用出国，也能感受体验一流教育质量。

工作机会多，毕业后也可留在当地工作。

话虽如此，可是如果没有选对专业，高性价比也会变成白花钱，我们在面临越来越多的选择下,该如何选择就业优势相对高的专业，使得高性价比更加凸显呢?金融专业同时作为中国留学生组热爱的金融专业，再加上与纽约，伦敦和香港并称为全球四大金融中心之一的美名，香港拥有几乎所有的世界著名银行、投资机构和保险公司都在香港有常驻机构和大量分支机构。

因此，在香港，金融人才的需求是巨大的。

而且由于其金融业的领先地位和极高的国际化程度，在香港从事金融业十分便于进入全球金融系统和跨国金融机构。

但是现在香港的金融硕士申请竞争激烈程度丝毫不亚于英美名校申请，要想进入自己心仪的大学，必须早规划，早准备。

推荐院校：香港大学、香港中文大学、香港理工大学、香港城市大学、香港浸会大学申请要点--香港大学香港大学：倾向招收有两年在金融机构，银行，政府监管部分工作经验的学生。

如果没有工作经验，学生需要有很强的学术背景才有希望被录取。

虽然没有硬性规定要提交GMAT 成绩，但有高分GMAT成绩的学生相对会有竞争优势。

香港大学的金融硕士专业包括4门针对CFA(Chartered FinancialAnalysts)考试的金融分析基础课，有效地拓宽学生对的定量分析，财务报表分析，经济学和资产评估基础的了解，学生上完这些课后可以更好地去应对CFA level2考试。

学生学完那4门金融分析基础课后，还可以根据自己的兴趣和职业目标继续学下去选择风险管理(Risk Management)和金融工程(FinancialEngineering)这两个分支。

风险管理分支有5门课，金融工程有6门课。

REF3030AIDBZR

深圳市讯锋科技有限公司
SHENZHEN XUNFENG TECHNOLOG LTD. HTTP:/ 电话:13751074754 传真:0755-83259733
深圳市福田红荔路上步工业区上航大厦 302 室
规格承认书
SPECIFICATON FOR APPROVAL 承认书编号: SZ-XF-0105 客户 CUSTOMER 深圳科士达科技股份有限公司
q MicroSIZE PACKAGE: SOT23-3 q LOW DROPOUT: 1mV q HIGH OUTPUT CURRENT: 25mA q HIGH ACCURACY: 0.2% q LOW IQ: 50µA max q EXCELLENT SPECIFIED DRIFT PERFORMANCE: 50ppm/°C (max) from 0°C to +70°C 75ppm/°C (max) from –40°C to +125°C
PRODUCT REF3012
PACKAGE-LEAD SO T23-3
"
REF3020
"
SOT23-3
"
DBZ
"
–40°C to +125°C
"
R30B
"
REF3025
"
SOT23-3
"
DBZ
"
–40°C to +125°C
"
R30C
"
REF3030
"
SOT23-3
"
DBZ
"
–40°C to +125°C
ELECTROSTATIC DISCHARGE SENSITIVITY

胶囊内镜和小肠镜

▪ 小肠疾病的某些并发症
▪ 胃肠道改道手术后的内镜检查
毕II式手术或Roux．en-Y手术后ERCP术；减肥手术。
▪ 普通全结肠镜失败者
禁忌证
严重的心肺功能不全、处于休克等危重状态者、不合作者、小肠镜插入途径有严重急性炎症和内脏穿孔者等应视为小肠镜检查的禁忌证。
告知内容
▪ 检查目的 ▪ 检查过程 ▪ 检查费用 ▪ 并发症及应对措施 ▪ 告知时间、医生签名 ▪ 患者及家属签名
6.胃肠动力障碍方面的研究
▪ CE依靠消化道的运动功能向前推进，因此CE反应消化道的运动功能；
▪ Appleyard等及Korman 等用胶囊内镜对消化道运动及传输时间进行了初步研究，认为对消化道的动力研究有一定的价值。
优点：
1、操作简便、无创伤性、无需镇静剂； 2、一次性使用，卫生安全，无任何交叉污染； 3、检查过程方便自如，可为患者提供全胃肠道图像。
检查前15分钟莫沙必利口服（据患者情况，胃肠动力差的患者服用）。
检查前30分钟口服二甲硅油
▪ 不明原因消化道出血(OGIB)占CE检查总数的70%-80%，总体诊断率约50%-80%，CE对成年OGIB的作用已被明确
▪ 荟萃分析显示：CE与双气囊小肠镜相比，两者诊断率相似，但是CE有较高的全小肠诊断率（90.6%-62.5%，P<0.05)
操作的病人，清醒镇静(安定+哌替啶)是最常用的、也是较理想的方式
附件与辅助设备
活检钳黏膜下注射针标记物: 墨汁, ICG, 钛夹造影剂 EUS设备治疗性附件
＋ OBCU
EVIS 240 内镜系统
EVIS 260
ST-SB1
SIF-Q260

CE 安全要求与产品说明书

IMPORTANT -CE & SAFETY REQUIREMENTSProduct must be mounted, inside a suitable enclosure providing environmental protection to IP65 or greater.To maintain CE EMC requirements , input wires must be less than 3 metres.The product contains no serviceable parts , or internal adjustments. no attempt must be made to repair this product. Faulty units must be returned to supplier for repair. This product must be installed by a qualified person. All electrical wiring must be carried out in accordance with the appropriate regulations for the place of installation. Before attempting any electrical connection work, please ensure all supplies are switched off.ABSOLUTE MAXIMUM CONDITIONS ( To exceed may cause damage to the unit) :-Supply Voltage± 30 V dc (Protected for over voltage and reverse connection)Current with over voltage± 100 mAInput Voltage± 3 V between any terminalsAmbient Temperature (-40 to 85) °C Humidity (10 to 95) % RH (Non condensing)SEM206/P USER GUIDEEvery effort has been taken to ensure the accuracy of this document, however we do not accept responsibility for damage, injury, loss or expense resulting from errors and omissions, and we reserve the right of amendment without notice.Important -Please read this document before any installing.PRODUCT SPECIFICATIONRECEIVE AND UNPACKINGCONFIGURATIONPlease refer to the product data sheet for full specification, available to down load at .Please inspect the packaging and instrument thoroughly for any signs of transit damage. If the instrument has been damaged, please notify your supplier immediately.The following parameter can be configured by simply entering as prompted by the software package.· Low range· High range· Units (°C, °F)· Burnout (direction of output current on sensor burnout)Factory default:Low Range= 0High Range= 100Units= °CBurnout= UPSCALE IMPORTANT Do not attempt to configure the SEM206 P when connected to a loop supply.Download @SEM206 PUSB SPEEDLINKSTATUS USB CONFIG-UNITSUPPLY (Vs) = (10 to 30) V dcINPUT CONNECTIONPT100 wire must be equal length and type .To maintain CE compliance cable length must be less than3 Metres.OUTPUT CONNECTIONUse twisted pair or screened cables for cable lengthsgreater than 30 Metres. Max cable length 1000 Metres.Ensure loop is grounded at one point.ELECTRICAL INSTALLATIONScrew DriverTURN OFF SUPPLY BEFORE WORKING ON ANY ELECTRICAL CONNECTIONINPUTPT100。

可朗妥安全数据表说明书

SECTION 1: Identification of the substance/mixture and of the company/undertaking1.1. Product Identifier Product name Canon Ink Tank CLI-581XL< C >Product Code(s)2049C1.2. Relevant identified uses of the substance or mixture and uses advised against UseInk for Ink Jet Printer1.3. Details of the supplier of the safety data sheet Supplier ImporterCanon Europa N.V.Bovenkerkerweg 59, 1185XB Amstelveen, The Netherlands +31 20 5458545, +31 20 5458222Manufacturer Canon Inc.30-2, Shimomaruko 3-Chome, Ohta-ku, Tokyo 146-8501, Japan 1.4. Emergency Telephone Number *1 Kontakt Giftlinien på tlf.nr.: 82 12 12 12 (åbent 24 timer i døgnet). Se punkt 4 om førstehjælp.*2 Only for the purpose of informing medical personnel in cases of acute intoxications.*3 Ask for Poison InformationSECTION 2: Hazards identification2.1. Classification of the substance or mixtureClassification according to Regulation (EC) No 1272/2008Not classified2.2. Label ElementsLabelling according to Regulation (EC) No 1272/2008112Safety Data SheetMalta 112Bulgaria Netherlands +31 (0)30-2748888 [*2]112Poland 112Version : 03Portugal +351 808 250 143CroatiaRomania +40 21 318 36 06+385 (0)1-23-48-342Slovakia +421 2 5477 4166Slovenia 112Cyprus Spain1121401Sweden 112 [*3]Issuing date : 19-Apr-2017United Kingdom 111 (UK only)Czech Republic Iceland 112+420 224919293Liechtenstein 145Norway+47 22 59 13 00Denmark Switzerland145+45 82 12 12 12 [*1]Estonia 16662SDS # : ICW 1784 R - 03 EU ENFinland +358 (0)9 471977France +33 (0)1 45 42 59 59Greece +30 210 7793777Austria Hungary +36 80 20 11 99+43 (0) 1 406 43 43Italy+39 (0)55 7947819Revision date : 31-Aug-2018Latvia+371 67042473Belgium Lithuania +370 687 53378+32 (0) 70 245 245LuxembourgHazard pictogramsNot requiredSignal wordNot requiredHazard statementsNot requiredPrecautionary statementsNot requiredOther InformationContains 1,2-benzisothiazol-3(2H)-one.May produce an allergic reaction.Contains less than 30% of components with unknown hazards to the aquatic environment.2.3. Other HazardsNoneSECTION 3: Composition/information on ingredients 3.2. MixturesChemical name CAS-No EC-No REACH registrationnumber Weight %Classification (Reg.1272/2008)Note toOtherHazardsGlycol CBI CBI CBI10 - 15NoneGlycerin56-81-5200-289-5None 5 - 10NoneUrea compound CBI CBI CBI 5 - 10Eye Irrit. 2 (H319)Substituted phthalocyanine salt CBI CBI CBI 1 - 5Eye Dam. 1 (H318)Aquatic Chronic 3 (H412) Water7732-18-5231-791-2None60 - 80NoneFull texts of Hazard statement(s) are listed in SECTION 16Note to Other Hazards : The following substance(s) is (are) marked with (1), (2) and/or (3)- (1) Substance for which EU Occupational Exposure Limit(s) is (are) established (See SECTION 8)- (2) PBT substance or vPvB substance under Regulation (EC) No 1907/2006- (3) Substance listed in Candidate List of SVHC for Authorisation under Regulation (EC) No 1907/2006In case a safety data sheet supplied under (EC) No 1907/2006 Article 31-3 is necessary, please contact us.SECTION 4: First aid measures4.1. Description of first aid measuresInhalation Move to fresh air. Get medical attention immediately if symptoms occur.Ingestion Rinse mouth. Drink 1 or 2 glasses of water. Get medical attention immediately if symptomsoccur.Skin Contact Wash off immediately with soap and plenty of water. Get medical attention immediately ifsymptoms occur.Eye Contact Flush with plenty of water. Get medical attention immediately if symptoms occur.4.2. Most important symptoms and effects, both acute and delayedInhalation None under normal use. Symptoms of overexposure are dizziness, headache, tiredness,nausea, unconsciousness, cessation of breathing.Ingestion None under normal use. Ingestion may cause gastrointestinal irritation, nausea, vomitingand diarrhea.Skin Contact None under normal use.Eye Contact None under normal use. May cause slight irritation.Chronic Effects None under normal use.4.3. Indication of any immediate medical attention and special treatment neededNoneSECTION 5: Firefighting measures5.1. Extinguishing mediaSuitable extinguishing mediaUse CO 2, water, dry chemical, or foam.Unsuitable extinguishing mediaNone5.2. Special hazards arising from the substance or mixtureSpecial HazardNoneHazardous combustion productsCarbon dioxide (CO 2), Carbon monoxide (CO)5.3. Advice for firefightersSpecial protective equipment for fire-fightersNoneSECTION 6: Accidental release measures6.1. Personal precautions, protective equipment and emergency proceduresAvoid contact with skin, eyes and clothing.6.2. Environmental PrecautionsKeep out of waterways.6.3. Methods and material for containment and cleaning upWipe up with adsorbent material (e.g. cloth, fleece).6.4. Reference to other sectionsNoneSECTION 7: Handling and storage7.1. Precautions for safe handlingAvoid contact with skin, eyes and clothing. Clean contaminated surface thoroughly. Use with adequate ventilation.7.2. Conditions for safe storage, including any incompatibilitiesKeep in a dry, cool and well-ventilated place. Keep out of the reach of children. Keep away from direct sunlight. Keep away from heat and sources of ignition.7.3. Specific end usesInk for Ink Jet Printer. Obtain special instructions before use.SECTION 8: Exposure controls/personal protection8.1. Control parameters Exposure LimitsChemical nameEU OEL Austria Belgium Bulgaria Cyprus Glycerin 56-81-5None None TWA: 10 mg/m 3None NoneChemical nameCzech Republic Denmark Finland France GermanyGlycerin 56-81-5TWA: 10 mg/m 3Ceiling: 15 mg/m 3NoneTWA: 20 mg/m 3TWA: 10 mg/m 3DFG TWA: 200 mg/m 3inhalable fraction Ceiling / Peak: 400mg/m 3 inhalablefraction Chemical nameGreece Hungary IrelandItaly NetherlandsGlycerin 56-81-5TWA: 10 mg/m 3None TWA: 10 mg/m 3 mist STEL: 30 mg/m 3 mistNone None Chemical namePoland PortugalRomania Slovakia SpainGlycerin 56-81-5TWA: 10 mg/m 3inhalable fractionTWA: 10 mg/m 3 mist NoneNone TWA: 10 mg/m 3 mistChemical nameSweden United Kingdom Norway Switzerland Turkey Glycerin 56-81-5NoneTWA: 10 mg/m 3 mistNoneTWA: 50 mg/m 3inhalable dust STEL: 100 mg/m 3inhalable dustNone8.2. Exposure controlsAppropriate engineering controlsNone under normal use conditions.Individual protection measures, such as personal protective equipmentEye/face ProtectionNot required under normal use.Skin ProtectionNot required under normal use.Respiratory ProtectionNot required under normal use.Thermal hazardsNot Applicable SECTION 9: Physical and chemical properties9.1. Information on basic physical and chemical properties AppearanceCyan ; Liquid OdorSlight odorOdor threshold No data available pH7 - 9Evaporation RateNo data availableNo data availableFlash Point (°C)> 93.0°C (Tag. Closed Cup.); estimated Melting/Freezing point (°C)No data available Boiling Point/Range (°C)Flammability (solid, gas)Not Applicable Flammability Limits in AirUpper Flammability Limit None; estimatedLower Flammability Limit None; estimatedVapor pressure No data availableVapor density No data availableRelative density 1.0 - 1.1Solubility(ies)Water; misciblePartition coefficient: n-octanol/water No data available Autoignition Temperature (°C)None; estimated Decomposition Temperature (°C)No data available Viscosity (mPa s) 1 - 5Explosive properties None; estimatedOxidizing properties None; estimated9.2. Other InformationNo data availableSECTION 10: Stability and reactivity 10.1. ReactivityNone10.2. Chemical stabilityStable10.3. Possibility of Hazardous ReactionsNone10.4. Conditions to AvoidNone10.5. Incompatible materialsAcids, Bases, Oxidizing agents, Reducing agents.10.6. Hazardous Decomposition ProductsCarbon dioxide (CO 2), Carbon monoxide (CO), and/or Ammonia.SECTION 11: Toxicological information 11.1. Information on toxicological effectsAcute toxicity No data availableSkin corrosion/irritation Non-irritant (Estimate) (OECD Guideline)Serious eye damage/eye irritation Minimal irritant (Estimate) (OECD Guideline) Sensitization Non-sensitizer (Estimate) (OECD Guideline)Germ cell mutagenicity Ames test: NegativeCarcinogenicity No data availableReproductive Toxicity No data available STOT - single exposure No data available STOT - repeated exposure No data available Aspiration hazard No data available Other InformationNo data availableSECTION 12: Ecological information12.1. Toxicity Ecotoxicity effects No data available12.2. Persistence and degradability No data available12.3. Bioaccumulative potential No data available 12.4. Mobility in soil No data available12.5. Results of PBT and vPvB assessmentThis preparation contains no substance considered to be persistent, bioaccumulating nor toxic (PBT).This preparation contains no substance considered to be very persistent nor very bioaccumulating (vPvB).12.6. Other adverse effects No data availableSECTION 13: Disposal considerations13.1. Waste treatment methodsDispose of in accordance with local regulations.SECTION 14: Transport information14.3. Transport Hazard Class 14.1. UN numberNone None 14.4. Packing Group None14.5. Environmental Hazards Not classified as environmentally hazardous under UN Model Regulations and marine pollutant under IMDG Code.14.2. UN Proper Shipping Name 14.6. Special Precautions for usersIATA: Not regulatedNoneSECTION 15: Regulatory information15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture (EC) No 1907/2006 Authorisation Not regulated (EC) No 1907/2006 Restriction Not regulated (EC) No 1005/2009Not regulated (EC) No 850/2004Not regulated (EU) No 649/2012Not regulated Other InformationNone15.2. Chemical safety assessment NoneSECTION 16: Other informationFull text of H-Statements referred to under sections 2 and 3H318 - Causes serious eye damage H319 - Causes serious eye irritationH412 - Harmful to aquatic life with long lasting effectsKey literature references and sources for data- World Health Organization International Agency for Research on Cancer, IARC Monographs on the Evaluation on the Carcinogenic Risk of Chemicals to Humans- EU Regulation (EC) No 1907/2006, (EC) No 1272/2008, (EC) No 1005/2009, (EC) No 850/2004, (EU) No 649/2012Key or legend to abbreviations and acronyms used in the safety data sheet - PBT: Persistent, Bioaccumulative and Toxic - vPvB: very Persistent and very Bioaccumulative - SVHC: Substances of Very High Concern- EU OEL: Occupational exposure limits at Union level under Directive 2004/37/EC and (EU) 2017/2398, 98/24/EC, 91/322/EEC,2000/39/EC, 2006/15/EC, 2009/161/EU and (EU) 2017/164.- TWA: Time Weighted Average - STEL: Short Term Exposure Limit- GHS: Globally Harmonized System of Classification and Labelling of Chemicals - IARC: International Agency for Research on Cancer - IATA: International Air Transport Association - CBI: Confidential Business Information Issuing date :19-Apr-2017Revision date :31-Aug-2018Revision NoteSECTION 3 and 16 revisedThis product falls under (EC) No 1907/2006 Article 31-3.DisclaimerThe information provided on this SDS is correct to the best of our knowledge, information and belief at the date of its publication. The information given is designed only as a guide for safe handling, use, processing, storage,transportation, disposal and release and is not to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be valid for such material used in combination with any other material or in any process, unless specified in the text.14.7. Transport in bulk according to Annex II of MARPOL and the IBC CodeNot Applicable。

讲义 - PC 为施耐德制作的材料

Tough强韧
Impact & Abuse Resistant Excellent Mechanical & Electrical Properties Cold and High Temperature Performance Flame Retardant
LEXAN
Stable稳定
Dimensional Stability Predictable Long Term Properties Excellent Weatherability & Thermal Stability
LEXAN ® EXL
Transparent
EXRL0117 EXRL0109 EXRL0089 EXRL0118 EXRL0116 a EXRL0090 EXRL0137 d EXRL0000 a
thermalstabilitylexan产品线增强级非增强级注塑级结构发泡级挤出级通用级耐热级加纤增强级阻燃级高流动级型材挤出挤吹注吹级耐磨损级医疗器械光学级汽车lexan?polycarbonateresins超级耐用lexan通用级材料lexan?polycarbonateresinsinjectionmolding通用级meltflowindex55meltflowindex70meltflowindex85meltflowindex105ul94hbul94hbul94v2ul94hbul94hbul94v2303101r201r191193194141r143r141s241r243r241smeltflowindex175ul94v2ul94hb121r123r121s221r末位数1普通级别末位数3uv稳定级别末位数4符合食品卫生级别r易脱模级别s脱模性能加强unfilledecofrlexan?gradeinjectionmolding925v015mm915rv011mm945v011mmv015mmopaquenonuvv008mmbpl1000955opaqueuv925uv015mm945uv015mm955uv015mm945av030mm925av030mm955av030mmtransparentuv925auv030mm945auv030mm955auv030mmtransparentnonuv500ecrv023mm3412ecrv015mm环保阻燃lexanpc920v015mm940v011mmv015mm950923v015mm943v015mm953v015mmfilledeco920av030mm940av030mm950av030mm923av030mm943av030mm953av030mm500rv015mm505rv015mm3412rv030mm5va3mmml6411lexan加纤增强级加纤增强级10500kpsimodulus500r505r500ecr3413r3413hf3433r503r3412r3412ecr3414rgeneralpurpose20800kpsimodulus301000kpsimodulus401400kpsimodulusuvstabilizedgeneralpurposeuvstabilizedgeneralpurpose

AyersGTS 使用手冊说明书

AyersGTS工作站使用手冊Ayers Solutions Limited修改紀錄版本日期詳情copyV1.0 22-Mar-04 InitialV1.1 25-Mar-04 Update the section “Recommended Daily Operation Flow”V1.2 18-Apr-04 Update the “Input Order” sectionUpdate the “Upload Interface File” sectionUpdate the “Client Master” screenAdd section “Enable Internet Trading For Client Acc”V1.4.5 13-Jul-04 Update the “Input Order” SectionV1.4.12 20-Jan-05 Update the “save/load/clear desktop setting” SectionAdd “Report” sectionV1.5 15-Mar-05 Add the “Enable IVR trading” sectionAdd the “Filter rows in order journal” sectionAdd the “Update/Cancel multiple orders” sectionAdd section “Sell Transaction Amount Limit”V1.6.4 13-Mar-06 Update with latest information up to v1.6.4graphicstheV1.6.6 22-May-06 UpdateV1.6.8 28-Aug-06 Add new credit line “Nominal Deviation Limit” on Appendix AV1.6.8a 30-Nov-06 Add the “Run Batch Report” SectionV1.7.6 10-Oct-07 User manual revampV1.8.2 18-June-08 User manual revampV1.8.3 1-Aug-08 Add Manual Trade and Odd Lot Trade sectionV1.8.3 4-Aug-08 Add enhanced stop limit order with trailing stop sectionV1.9.0 17-Nov-08 Add Futures functionV1.9.3 22-Jun-09 User manual revampV1.10.0 8-Feb-10 User manual revampV1.10.3 26-June-10 User manual revampV1.10.4 8-Jul-10 Add “Last Updated Time” in “O/S Order” and “Today Orders” pageof Client Portfolio EnquiryAdd Reject Confirmed Cash Deposit/WithdrawCan disable the client a/c field input in Client PortfolioV1.10.5 13-Aug-10 Able to lock/unlock windows ; Group the windows in GTSAdd the URL access right in Market InformationAble to remove the button “Cancel All” and “Close All Positions” inGlobal Market Layout 2; Able to show column ‘Condition’ (OrderType + Condition) in Order JournalV1.10.6 22-Oct-10 Batch Interface File Import/Export SchedulerNew fields (e.g. Trigger price, fee, exchange order info) availablein Order Journal ;Show average price in Client Portfolio and Client Product PositionV1.10.7 26-Nov-10 Allow to copy/duplicate report job item;Allow to send email for report jobV1.10.8 28-Dec-10 New Function : User Reset PasswordV1.11.0 15-Jan-11 User manual revampV1.11.1 19-Feb-11 Request add “currency” column in order journal and trade journalAdd margin calculation mode in Setup ExchangeV1.11.2 18-June-11 User manual revampV1.11.3 23-Aug-11 User manual revampV1.11.4 18-Jun-11 User manual revampV1.11.5 21-Jul-11 User manual revampV1.11.6 2-Sep-11 User manual revampV1.11.7 1-Feb-11 User manual revampV1.12.1 10-Mar-12 User manual revampV1.12.4 14-Sept-12 User Manual revampV1.13.1 12-April-12 User Manual revampV1.13.5 30-May-14 User Manual revampV1.13.6 18-Dec-15 User Manual revampV1.13.7 15-Feb-16 User Manual revampV1.13.8 20-Jul-18 Cyber Security目錄1. 序 (10)2. 關於AyersGTS (12)3. 關於AyersGTS Lite (12)4. 開始使用☆ (13)4.1 登入☆ (13)4.2 更改密碼☆ (13)4.3 登出☆ (14)5. 使用介面☆ (15)5.1 主視窗☆ (15)5.2 常用圖示☆ (15)5.3 時鐘☆ (16)5.4 螢幕鎖☆ (16)5.5 載入桌面設定☆ (17)5.6 儲存桌面設定☆ (17)5.7 清除桌面設定☆ (18)5.8 查詢已開啟的版面☆ (18)5.9 傳送今日消息(網上客戶) (19)5.10 傳送今日消息 (20)5.11 顯示今日消息☆ (20)5.12 傳送電郵 (21)5.13 強迫使用者登出 (21)5.14 更改用戶設定 (23)5.15 客戶快捷鍵設定☆ (27)5.16 客戶群組快捷鍵設定 (29)5.17 客戶下單群組快捷鍵設定 (29)5.18 經記行即時報價顏色 (30)5.19 鎖定視窗位置及大小☆ (33)5.20 視窗群組☆ (34)5.21 放大/縮小視窗☆ (35)5.22 用戶/客戶主任/客戶戶口快速搜尋模式 (36)5.23 選擇字體顏色☆ (37)5.24 選擇背景顏色☆ (37)6. 系統設定 (38)6.1 設定系統參數 (38)6.1.1 設定 1 (38)6.1.2 設定 2 (39)6.1.3 設定 3 (42)6.1.4 設定 4 (42)6.1.5 設定５ (44)6.1.6 設定６ (44)6.2 密碼規格 (46)6.3 設定貨幣 (49)6.4 銀行 (49)6.5 交易限額政策 (50)6.6 批核級別 (51)6.7 用戶群組 (53)6.8.2 用戶群組 (57)6.8.3 用戶權限 (58)6.8.4 備註 (59)6.8.5 可管理客戶戶口 (60)6.8.6 交易限額 (61)6.8.7 設定 (62)6.8.8 快捷鍵 (63)6.8.9 交易所 (65)6.9 重設用戶密碼 (66)6.10 用戶(LITE網上用戶) (67)6.11 客戶主任群組 (68)6.12 客戶主任 (68)6.13 客戶戶口類別 (68)6.13.1 給客戶類別設置交易限額及信貸比率 (69)6.14 客戶群組 (70)6.15 客戶下單群組 (71)6.15.1 建立客戶下單群組 (72)6.15.2 分配客戶到特定下單群組 (73)6.15.3 客戶下單群組快捷鍵設定 (74)6.16 客戶戶口 (75)6.16.1 客戶通知訊息 (75)6.16.2 網上客戶使用即時報價服務 (78)6.16.3 使用音頻電話交易服務 (79)6.16.4 設置客戶交易限額及信貸比率 (80)6.16.5 設置客戶佣金率 (81)6.16.6 人證港幣交易通 (82)6.16.7 拒絕客戶買入 / 沽出指定產品 (84)6.16.8 待跟進記錄 (86)6.17 交易所 (91)6.17.1 啟用/停用訂單類型 (95)6.18 交易產品群組 (98)6.19 產品資料 (99)6.19.1 按揭級別 (101)6.20 訂單路由群組 (103)6.21 訂單路由 (105)6.22 關連產品 (105)6.23 認購新股 (IPO) (107)6.23.1 資料 (107)6.23.2 數量 / 金額表 (109)6.23.3 申請 (111)6.23.4 電郵傳送認購結果 (114)6.24 報表工作項目 (117)6.25 多檔案匯入 / 匯出 (120)6.25.1 多檔案匯入 / 匯出- 匯入 (120)6.25.2 多檔案匯入 / 匯出 - 匯出 (122)6.26 多檔案匯入 / 匯出自動執行-匯入 (123)6.26.1 多檔案匯入 / 匯出自動執行- 匯出 (124)7.1.2 設定訂單資料夾☆ (127)7.1.3 篩選訂單資料夾訂單☆ (129)7.1.4 查詢訂單資料☆ (130)7.1.5 使用訂單功能表☆ (131)7.1.6 更改訂單☆ (132)7.1.7 取消訂單☆ (133)7.1.8 更改 / 取消多筆訂單☆ (134)7.1.9 新增 / 移除欄位☆ (136)7.2 交易成交資料夾☆ (140)7.3 成交量查詢 (143)7.4 追收保證金客戶資料夾 (143)7.5 追收保證金客戶資料夾(單一貨幣計算) (146)7.6 輸入訂單☆ (146)7.6.1 使用輸入訂單畫面 (證券市場) ☆ (146)7.6.2 使用輸入訂單畫面 (環球市場) ☆ (160)7.6.3 輸入訂單 (環球市場, 只限買入)☆ (161)7.6.4 程式買賣 (香港交易所-股票) ☆ (167)7.7 買賣數量選擇器☆ (176)7.8 使用訂單快捷鍵☆ (177)7.9 輸入已成交訂單 (179)7.10 輸入新股認購 (180)7.11 輸入新股認購(網上用戶) (181)7.12 輸入新股認購(版面一) (181)7.13 查詢訂單 (184)7.14 客戶戶口資料☆ (185)7.14.1 產品結存 ☆ (185)7.14.2 待成交訂單☆ (186)7.14.3 新增 / 移除欄位☆ (186)7.14.4 篩選訂單☆ (190)7.14.5 今日訂單☆ (191)7.14.6 新增 / 移除欄位☆ (194)7.14.7 篩選訂單☆ (197)7.14.8 今日成交☆ (198)7.14.9 資料☆ (198)7.14.10 交易分配☆ (199)7.14.11 待跟進記錄☆ (200)7.14.12 新股認購 (201)7.15 客戶下單群組戶口資料 (201)7.16 客戶產品持貨查詢 (203)7.17 客戶盈虧查詢 (203)7.18 產品持貨總覽 (204)8.1 訂單批核資料夾 (205)8.2 客戶現金存款或提款 (207)8.3 客戶支票存款 (207)8.4 客戶現金存款或提款(小額) (208)8.5 批核客戶現金存款或提款 (208)8.6 批核客戶現金存款 (208)8.8 批核客戶現金提款 (209)8.9 上傳多筆客戶現金存款或提款 (210)8.10 拒絕已批核客戶現金存／提款 (210)8.11 客戶外幣轉換 (212)8.12 客戶現貨存入或提走 (213)8.13 上傳多筆客戶現貨存入或提走 (213)8.14 批核客戶現貨存入或提走 (214)8.15 拒絕已批核客戶現貨存入或提走 (214)8.16 客戶資產內部轉移 (214)8.17 客戶成交分配 (215)8.18 客戶成交分配 (相同平均價) (217)8.19 客戶訂單成交分配 (219)8.20 客戶訂單成交批次分配 (220)8.21 客戶群成交額監測 (220)8.22 上傳已執行交易 (221)9. 市場資訊☆ (222)9.1 即時報價 (AAStock, 香港) ☆ (222)9.2 即時報價總覽 (所有市場) ☆ (224)9.2.1 新增欄位☆ (225)9.2.2 隱藏產品輸入☆ (226)顯示市場深度☆ (227)9.2.3 2279.2.4 顯示市場成交記錄☆ (228)9.3 即時報價（香港股票，版面四）☆ (231)10. 交易員 (232)10.1 交易員訂單資料夾 (232)10.2 開啟OG (BSS功能) (233)10.3 大量取消及活動查詢 (234)10.4 交易員密碼更改提示 (235)10.5 人手交易 (BSS功能) (235)10.6 碎股盤/特別盤訂單輸入(BSS功能) (237)10.7 碎股盤/特別盤交易對單及查詢(BSS功能) (238)11. 報表☆ (239)11.1 產生報表☆ (241)11.2 列印報表☆ (242)11.3 文字複製☆ (243)11.4 報表搜尋☆ (244)11.5 單一/多重頁面檢視☆ (245)11.6 放大 / 縮小☆ (247)11.7 增加備註☆ (248)11.8 輸出報表☆ (249)11.9 報表工作項目 (250)11.10 報表工作 (251)11.11 執行報表自動產生工作 (252)11.12 開啟現存的報表 (253)12. 系統設定 (254)12.1 產品（SYS專用） (254)12.2 交易所假期(SYS專用) (255)14. 附錄 A: 交易限額運算程式 (258)14.18 客戶每日交易金額限額 (264)14.19 客戶每日買入交易金額限額 (264)14.20 客戶每日買入交易金額限額 (單一產品) (265)14.21 高風險產品買入限額 (265)14.22 貸款限額 (265)14.23 貸款限額(電子訂單) (266)14.24 港幣貸款限額 (266)14.25 港幣貸款限額(電子訂單) (266)14.26 高風險產品貸款限額 (267)14.27 貸款限額 (環球市場) (267)14.28 貸款/投資總值限額(%) (267)14.29 離價限額 (%，電子訂單) (267)14.30 離價限額 (電子訂單) (267)14.31 離價限額 (268)14.32 離價限額 (%) (268)14.33 離價限額 (%) (環球市場) (268)14.34 離價限額 (環球市場) (269)14.35 特別訂單限額 (269)14.36 市價盤限額 (269)14.37 購買力限額 (269)14.38 購買力限額 (電子訂單) (269)14.39 購買力限額 (環球市場) (270)14.40 交易數量限額(產品) (270)14.41 交易數量限額 (270)14.42 限制商品買賣限額 (271)14.43 不允許同時擁有相同產品及價錢之買入/沽出訂單 (271)14.44 沽空限額 (271)14.45 沽空限額 (電子訂單) (271)14.46 高風險產品沽空限額 (272)14.47 人證港幣交易通客戶只可買賣人民幣產品 (272)14.48 買入低價之認股證(電子訂單) (272)14.49 客戶群組每日買入交易金額限額 (272)14.50 客戶群組每日交易金額限額 (273)14.51 客戶群組每日沽出交易金額限額 (273)14.52 公司每日交易金額限額 (273)14.53 公司每日買入交易金額限額 (273)14.54 公司每日沽出交易金額限額 (274)14.55 產品每日買入交易金額限額 (274)14.56 產品每日買入交易金額限額 (電子訂單) (274)14.57 產品每日買入交易金額限額 (單一客戶) (電子訂單) (274)14.58 產品每日沽出交易金額限額 (275)14.59 用戶每日買入交易金額限額 (275)14.60 用戶每日沽出交易金額限額 (275)15.1 系統裝置 (276)15.1.1 如何下載AyersGTS? (276)15.1.2 為何有時候不能升級GTS? (276)15.1.3 為何在網上不能瀏覽報價及交易資料區? (不適用於期貨/期權市場) (276)15.1.5 為何有時登入不到GTS? (276)15.1.6 輸入訂單裡的數量有那些快捷鍵? (276)15.1.7 如何不顯示客戶的聯絡資料? (276)15.1.8 如何使用Good Till Day? (此功能需要申請) (276)15.2 訂單拒絕原因 (277)15.2.1 為何訂單拒絕 'by price warning'? (277)15.2.2 為何訂單拒絕 'by invalid order price'? (不適用於期貨/期權市場) (277)15.3 交易限額 (277)15.3.1 交易限額政策在系統裡是如何運作? (277)15.3.2 如何替公司增加新的交易限額? (277)15.3.3 香港證券市場公司內有多少種客戶戶口? (277)15.3.4 如何替這4種戶口設定跟公司不一樣的交易限額? (277)15.3.5 如何替個別客戶設定跟公司不一樣的交易限額? (277)15.3.6 什麼是交易限額政策中的提示如風險高於? (277)15.3.7 什麼是交易限額政策中的需批核如風險大於? (278)15.3.8 什麼是交易限額政策中的拒絕訂單如風險大於? (278)15.3.9 貸款限額和購買力限額有什麼分別? (不適用於期貨/期權市場) (278)15.3.10 衍生工具產品買賣的相關問題？ (278)15.3.11 如何給用戶開設新的批核級別? (278)15.4 用戶及客戶設定 (279)15.4.1 如何新增客戶主任? (279)15.4.2 如何新增用戶? (279)15.4.3 怎樣設定用戶的權限? (279)15.4.4 如何替個別用戶設定跟公司不一樣的輸入訂單設定? (279)15.4.5 如何新增客戶? (279)15.4.6 在香港證券市場，甚麼是可按揭比率 (%) 和可按揭信貸比率 (%)? (279)15.4.7 在香港證券市場，甚麼是現金信貸比率 (%)? (279)15.4.8 如果客戶是網上客戶，應怎設定? (不適用於期貨/期權市場) (279)15.4.9 如何設定客戶不收取電郵訂單通知訊息? (279)15.4.10 如何設定示範用的客戶戶口? (279)15.4.11 示範用的客戶戶口有甚麼用處? (280)15.4.12 如何替用戶解鎖? (280)15.4.13 如何不讓網上客戶下訂單卻只讓他作查詢? (不適用於期貨/期權市場) (280)15.4.14 如果用戶群組和該群組裡的用戶設定不同的權限會怎樣? (280)15.4.15 如何給用戶及客戶收看報價? (不適用於期貨/期權市場) (280)15.4.16 如何設定客戶佣金? (280)15.4.17 系統如何計算佣金? (280)15.4.18 怎樣設定產品可按的比率? (不適用於期貨/期權市場) (280)15.4.19 怎樣替客戶存 / 取現金? (280)15.4.20 怎樣替客戶存 / 取現貨? (280)15.4.21 “用戶”內的“可管理客戶戶口”是如何設定? (281)15.4.22 客戶戶口類別可以隨時更改嗎? (281)15.4.23 客戶戶口裡的提醒備註是甚麼? (281)15.4.24 如何限制某客戶買賣某特定產品? (281)15.4.25 那裡可以查詢成交分配的訂單? (281)15.5 其他設定 (282)15.5.1 訂單的交易狀態是什麼意思 (NEW, WA...)? (282)15.5.2 為何在星期六做測試時所有訂單都傳送不到去香港交易所? (282)15.5.4 那裡可以找到訂單成交的詳情? (282)15.5.5 那裡可以找到訂單成交的對手牌? (不適用於期貨/期權市場) (282)15.5.6 那裡可以找到由誰更改了訂單? (282)15.5.7 怎樣在訂單資料夾內新增欄位? (282)15.5.8 經由網上客戶下的訂單，用戶可否在GTS中修改或取消? (282)15.5.9 那裡可以設定在下單時顯示或不顯示確認視窗? (282)15.5.10 如何替已成交了的錯誤訂單分配給正確的客戶? (283)15.5.11 BSS客戶每日如何開啟OG? (不適用於期貨/期權市場) (283)15.5.12 甚麼是BSS Cross Device? (不適用於期貨/期權市場) (283)15.5.13 怎樣買賣碎股? (不適用於期貨/期權市場) (283)15.5.14 什麼是確認訂單? (283)15.5.15 如何使用確認訂單? (283)15.5.16 如何還原確認訂單? (283)15.5.17 香港證券市場的輸入訂單版面2是怎樣使用? (283)15.5.18 如何使用“F1搜尋器”? (283)15.5.19 在訂單資料夾裡的播放聲響支援那種音樂格式? (284)15.5.20 在輸入已成交訂單可以輸入碎股嗎? (284)15.5.21 為何客戶戶口和產品資料不是最新? (284)15.5.22 為何在系統裡找不到從後台建立的客戶主任代碼? (284)15.5.23 如何設定高風險產品? (不適用於期貨/期權市場) (284)15.5.24 如何設定貨幣? (284)15.5.25 如何採用其他用戶的桌面設定? (284)15.5.26 為何網上交易資料區的文字無法正常顯示? (不適用於期貨/期權市場) (284)15.5.27 如何在訂單資料夾顯示備註? (284)15.5.28 甚麼是額外訂單批核上限(%)? (284)15.5.29 如何快速更改 / 取消多筆訂單? (284)15.5.30 為何建議勾選在“設置”裡的“不可增加訂單數量”? (285)15.5.31 交易資料能保存在系統多久? (285)15.5.32 在網上交易資料區的可動用資金是如何計算? (不適用於期貨/期權市場) (285)15.5.33 如何取消IPO? (不適用於期貨/期權市場) (285)15.5.34 在訂單號碼後的(-D, -E, -S)是甚麼意思? (285)15.6 產生報表 (286)15.6.1 為何報表沒有資料? (286)15.6.2 怎樣設定每日報表自動產生工作? (286)15.6.3 在訂單清單和訂單列表中的代碼分別代表什麼? (286)15.6.4 如何查詢由誰更改了系統設定? (286)15.6.5 如何查詢網上客戶存款 / 提款通知? (286)15.6.6 訂單列表跟訂單清單有甚麼分別? (286)15.6.7 如何查詢所有客戶的新股認購? (286)15.6.8 如何查詢所有未成交的訂單? (286)15.6.9 有關人證港幣交易通之交易方法？ (287)15.7 買賣盤種類詳細說明 (289)15.7.1 AyersGTS支援HKEx那些買賣盤種類? (289)15.7.2 何謂市價盤? (296)15.7.3 開市競價時段分那幾種? (只適用於香港證券市場) (296)1. 序本使用手冊提供如何使用A y e r s G l o b a l T r a d i n g S y s t e m(A y e r s G T S)的詳細步驟。

Thermo Scientific Genesys 30 P4400 辐照计量仪说明书

DESCRIPTIONThe P4400 Thermo Scientific Genesys 30 Spectrophotometer (G30) is an optical measurement device used to measure the absorbance of dosimeters. It is designed to be simple and fast with the highest performance and quality.The G30 Spectrophotometer uses specially designed dosimeter holders to fit a variety of dosimeters to include the B3 DoseStix and B3 WINdose dosimeters. This spectrophotometer is built for the fast-paced, high-volume processing environment, and reduces time spent at every step of the dosimetry process.APPLICATIONThe Genesys 30 is used for the measurement of optical absorbance of dosimeters using a select wavelength in the ultraviolet (UV) or visible spectrum, such as GEX B3 radiochromic film dosimeters, and FWT-60 radiochromic film dosimeters. SPECIFICATIONSPhysical Specifications:GEX PartNo. Description Product Dimensions Packaging Dimensions Product WeightP4400 Spectrophotometer – US Plug34.3 cm L x 38.1 cm W x 20.3 cm H(13.5” L x 15” W x 8” H) 58.4 cm L x 50.8 cm W x 33.0cm H(23” L x 20” W x 13” H)10.0 kg(22 lbs.)P4400EU Spectrophotometer – EU PlugP4400UK Spectrophotometer – UK PlugMaterial Molded plasticColor Grey and WhitePrinting Thermo Scientific logo plate on frontElectrical Supply 100–240 V, 50–60 Hz, selected automatically; 150 W maximumOptical Design Single-beamSpectral Bandwidth(s) 5 nmLight Source Tungsten-Halogen lampDetector Silicon PhotodiodeScan Ordinate Modes Absorbance, % Transmittance, % Reflectance, Kubelka-Munk, log (1/R), log (Abs), Abs*Factor, IntensityResolution >1.6 (peak-to-valley ratio; toluene in hexane)Wavelength Range: 325 –1100 nmAccuracy: ±2 nm (full range 325 to 1100 nm) Repeatability: ≤ 1 nmScanning Speed Automatic – up to 1200 nm/min; variablePhotometric Range: -3A to +3ADisplay Range: -3A to +3A; 0 to 200,000 %T; 0 to 9,999,999 C Accuracy – Instrument: ±0.002 A (0 – 0.3A)0.5% of ABS reading (0.301A – 2.5A) Repeatability: ±0.002 ADrift (Stability) <0.002 A/hrNoise: ≤0.001 A at 0A≤0.001 A at 1A≤0.002 A at 2AStray Light <0.1 %T at 340nm and 400nmBaseline Flatness <0.003 AKeypad Tactile rubber 23 keys with numeric keypadLocal Control Option Display: Touchscreen LCD panel; 800 x 480; 12.7 cm (5 in) diagonalIncluded Components:•Plastic insert plate with cuvette holder•USB thumb drive•Power cord•USB interface cordPackaging:Unit is shipped in a cardboard box with a form-fitting foam enclosure.Storage:Store the instrument in a cool and dry location.INSTALLATIONPlease refer to the Thermo Scientific Genesys 30 Spectrophotometer User Manual and all other references for explicit detail on the specifications, set up, operation, performance verification, and general care of the instrument. Information supplied herein should be considered supplemental and specific to dosimetry usage.CAUTION!Whenever the spectrophotometer has been stored or shipped, immediate exposure to room air can cause condensation damage. Move the shipping cartons to the installation location at least 24 hours before installation. This allows the instrument to equilibrate at room temperature before the shipping cartons are opened and protective packaging is removed.Unboxing:After at least 24 hours, open the shipping box and remove the documentation packet and USB thumb drive. Remove the instrument from its shipping box.Operating Environment:Instrument was designed for use under the following conditions:Temperature Range* 5°C to 35°C (41°F to 95°F)Relative Humidity <20% to 80% noncondensingAltitude 0m to 200m*Operating the instrument outside of this temperature range may cause permanent damage.Instrument performance should be verified when operating outside of the relative humidity (RH) and altitude ranges. GEX verified instrument performance at an altitude of approximately 1610m without any problems.The instrument should be positioned on a surface that is level and free of vibration. Anytime the instrument location is moved, the user is advised to conduct performance verification testing. Consider all GLP’s (Good Laboratory Practices) concerning cleanliness of the area.Power and USB:Connect the power cord and ensure the instrument’s sample chamber is empty. Power ‘ON’ the spectrophotometer. The unit will perform a series of self-checks that will take approximately one minute.Dosimeter Holders:Install the hot-swappable baseplate and holders according to GEX Doc# 100-168, Genesys 30 Dosimeter Holder System.IQ/OQ, CALIBRATION & PERFORMANCE VERIFICATIONCalibration:This instrument has been certified by Thermo Scientific to conform to approved test specifications. A Production Test Report is included with the instrument.The instrument is not required to be re-calibrated unless it is failing to meet performance verification specifications. See the section on ‘Care & Maintenance’ below for more information.Performance Verification:Please refer to page 26 of the Genesys 30 User Guide for complete information on performance verification.Operational Qualification (OQ):Upon completion of any and all PV activities, the user must verify the operation of the instrument. The user should verify the ability of the instrument to reproducibly perform fixed wavelength measurements. It is suggested to perform a gage R&R study for each dosimeter type that will be used. It is suggested to conduct thirty (30) repeated measurements of single dosimeters irradiated at low, middle, and high doses in the user’s range, and to reproduce this test for a minimum of three (3) days.To complete these measurements, the protocol below must be followed in order to make fixed wavelength dosimeter measurements:Protocol for Dosimeter Measurements:1.Insert the appropriate dosimeter holder according to GEX Doc #100-168, Genesys 30 Dosimeter Holder System.2.From the instrument home screen, highlight “Fixed” and press the enter ( ) button.3.Input the correct wavelength setting for the dosimeter type you are measuring and press “Done”.4.Ensure the dosimeter holder is empty, then zero the instrument by pressing the yellow “0.00” button.5.After the instrument is zeroed, insert a dosimeter to be measured and press the green diamond-shaped button. Themeasurement will be captured on the screen.6.After the measurement is recorded, you may remove the dosimeter and insert the next sample to be measured.Repeat step 5 above for all dosimeters.NOTE: Only 10 consecutive measurements may be taken. If more than 10 are needed, you must save or discard the data before proceeding. The recorded measurements may be output to an external USB drive in the form of .CSV files.Saving a Measurement Session:1.Insert a USB drive into the port located on the front of the G30.e the directional arrows to highlight the floppy disk icon and press enter.e the enter key to select “Export data to USB drive” from the window that is displayed and press OK.4.The top of the screen will display “Data is successfully saved” when complete.5.The USB drive may be removed and the data transferred to a computer for review and analysis.6.Clear out the measurements by selecting the trash can icon and press enter.CARE & MAINTENANCECleaning:The instrument’s exterior and the sample compartment should be periodically cleaned as part of a Preventative Maintenance program along with the dosimeter holder system. An instrument that is maintained and cared for will perform better and have a longer life. Complete cleaning instructions which include the proper materials can be found in the G30 User Guide. Instructions for cleaning the dosimeter holder system are located in GEX Doc# 100-168, Genesys 30 Dosimeter Holder System.Lamp Replacement:P4401 Tungsten-Halogen Lamp (light source) should be replaced every 800 hours. It is recommended to warm-up the instrument 15-30 minutes before use, and the lid may remain open during measurements. Measurement time for each dosimeter is less than 1 second.If the device requires service for any reason there are two options:(Note: Not all services are available with both options. Please consult with GEX or Thermo for more detail.)1.Depot Service:The Genesys 30 is designed to be serviced on-site, but from time to time it may need to be sent to Thermo Scientific in Madison, WI U.S.A. for repair or other services. Please contact GEX Customer Service for more information if depot service is required.2.On-site Service & Service Agreements:On-site service is available in some areas. A qualified technician can arrive on-site for cleaning, calibration, andmaintenance on your Genesys 30. Service agreements may also be available in your area. Contact GEX CustomerService for details.PRODUCT PHOTOSThermo Scientific Genesys 30 SpectrophotometerACCESSORIESGEX Part No. Description PurposeP4220Spectronic Standards Set Photometric accuracy, wavelength accuracy verificationP4330GEX Hot-Swappable Base Plate The base platform is the mount for all dosimeter holders as well as the laser micrometer and barcode reader. Beam tubes allow user to leave the lid open during measurements: protects measurements from stray light.P4332DoseStix Dosimeter Holder Dosimeter positioning for GEX DoseStix style dosimetersP4334WINdose Dosimeter Holder Dosimeter positioning for 1cm2 radiochromic film dosimetersP4336PMMA Dosimeter Holder Dosimeter positioning for Red and Amber Perspex PMMA dosimetersP4350Laser Micrometer Measures thickness of PMMA dosimeter inside the Evo220P4355Custom Gage blocks For calibrating the P4350 Laser MicrometerP4360B3 DoseStix Barcode Scanner Barcode scanner and mounting post for automated B3 DoseStix barcode readingP4401G30 Tungsten-Halogen LampAssembly Genesys 30 Spectrophotometer light sourcePRECAUTIONSPlease refer to the Thermo Scientific Site and Safety User Guide for additional information and the full listing of precautions.NOTICE:Immediate exposure to room (ambient) air can cause condensation damage whenever the spectrophotometer has been stored or shipped. Move the shipping cartons to the installation location at least 24 hours before installation. This allows the instrument to equilibrate with the room temperature before the shipping cartons are opened and protective packaging is removed.•Keep shipping cartons upright at all times. Damages due to improper moving techniques are not covered by the warranty.•Connect the spectrophotometer to a suitable uninterruptable power supply to minimize line current fluctuations that may alter the measurement or damage the spectrophotometer.•Keep the top cover closed and latched as much as possible. Minimize exposure of the spectrophotometer to airborne contaminants like smoke, dust, oil vapor, or chemical fumes.WARRANTY/GUARANTEEWarranty:Please refer to the Thermo Scientific product information for warranty information. User modifications are not warranted and are the sole responsibility of the user.Guarantee:1 year GEX satisfaction guarantee. Product may be returned within one year from the date of delivery for any customer dissatisfaction.REFERENCESReferences:•ISO 10012: Measurement Management Systems -- Requirements for Measurement Processes and Measuring Equipment•ISO/ASTM 51261: Calibration of Routine Dosimetry Systems for Use in Radiation Processing•ISO/ASTM 52628: Dosimetry for Use in Radiation ProcessingThermo Fisher Scientific Documents:•Genesys 30 User Guide•Genesys 30 Setup Guide•Genesys 30 Warranty Information•Site & Safety Information•Production Test ReportGEX Product Specification and Usage (PSU):•GEX Doc #100-168, Genesys 30 Dosimeter Holder SystemTo learn more about GEX products and services, visit or contact a GEX representative at +1 303 400-9640.。

Silk Central 12.1 发行说明说明书

发行说明Micro Focus575 Anton Blvd., Suite 510Costa Mesa, CA 92626Copyright © 2012 Micro Focus. All rights reserved. Portions Copyright © 2004-2009 BorlandSoftware Corporation (a Micro Focus company).MICRO FOCUS, the Micro Focus logo, and Micro Focus product names are trademarks orregistered trademarks of Micro Focus IP Development Limited or its subsidiaries or affiliatedcompanies in the United States, United Kingdom, and other countries.BORLAND, the Borland logo, and Borland product names are trademarks or registeredtrademarks of Borland Software Corporation or its subsidiaries or affiliated companies in theUnited States, United Kingdom, and other countries.All other marks are the property of their respective owners.2012-12-17ii内容Silk Central 12.1 发行说明 (4)Silk Central 12.1 的新增功能 (5)客户端数据隔离 (5)系统管理 (5)增强手动测试 (5)Testbook (5)Microsoft Office Word 报告模板 (6).NET 应用程序的代码分析 (6)项目导出/导入 (6)Issue Manager 增强功能 (6)MSTest 参数 (6)发生执行错误时停止 (6)删除结果文件 (6)Java 64 位代码分析 (7)集成增强功能 (7)Caliber 11.0（需要 hotfix 1） (7)StarTeam 12.5 (7)StarTeam 13.0 (7)IBM Rational DOORS 版本 9.4 (7)Jira 5 (7)不再支持的功能 (8)在将来的版本中不再支持的功能通告 (9)已测试和支持的软件 (10)系统需求和先决条件 (12)内容 | 3Silk Central 12.1 发行说明版本 12.12012 年 12 月这些说明包含可能不会出现在“帮助”中的重要信息。

GPL32610BV10（ProductBrief）

GPL32610BV10（ProductBrief）GENERALPLUS TECHNOLOGY INC. reserves the right to change this documentation without prior notice. Information provided by GENERALPLUS TECHNOLOGY INC. is believed to be accurate and reliable. However, GENERALPLUS TECHNOLOGY INC. makes no warranty for any errors which may appear in this document. Contact GENERALPLUS TECHNOLOGY INC. to obtain the latest version of device specifications before placing your order. Noresponsibility is assumed by GENERALPLUS TECHNOLOGY INC. for any infringement of patent or other rights of third parties which may result from its use.GMultimedia ProcessorNov. 18, 2013 Version 1.0P L 32610BTable of ContentsPAGE1. GENERAL DESCRIPTION (3)2. FEATURES (3)3. BLOCK DIAGRAM (4)4. DISCLAIMER (5)5. REVISION HISTORY (6)MULTIMEDIA PROCESSOR1. GENERAL DESCRIPTIONThe Generalplus GPL32610B, a highly integrated SoC (System-On a Chip), embedded 4M x16-bit SDRAM, offers agreat cost-effective and high performance ratio solution for Multimedia, Virtual 3D and interactive game applications. It is embedded the ARM7TDMI with 8K-byte unified ID-cache and many tremendous features such as JPEG CODEC engine, MPEG4 decoder with de-blocking engine, MP3 decoder accelerator, face detection engine, binarization function for GPID application, TFT-LCD interface, CMOS sensor interface, scalar engine, picture process unit (PPU), TV encoder with de-flicker engine, 16-channel sound process unit (SPU), SDRAM controller, ROM/SRAM/NOR FLASH/ NAND FLASH with BCH/ECC Memory controller, UART/IrDA interface, 4-channel DMA controller, 6-channel 16-bit timers, RTC,2 sets of SD/ MMC card interface, MS/ MS pro card interface, xD card interface, USB 2.0 mini-host/device, mono STN-LCD, interrupt controller, 2 sets of SPI (master/slave) controller, key scan controller, programmable I/O ports, stereo 16-bit DAC for audio playback, 2-channel DC-DC Boost control circuit, 1 data lane MIPI, 6-channel 12-bit ADC, MIC, PLL, and 38K-byte embedded SRAM.With a complete set of common system peripherals, the GPL32610B chip minimizes overall system cost and no additional component needs to be added. Not only does GPL32610B feature the high-speed performance, but it is also a cost-effective system and the most importantly - compatible with all ARM based programs.2. FEATURESARM7TDMI CPU with 8KB unified ID-cache, write buffer, embedded JTAG ICE, and working frequency up to 96MHz.38KB SRAM for local data buffer.Picture Process Unit. (PPU)z Four Text layersz1024 internal and 4096 extend Sprites.z Virtual 3D effect for text and sprite.z QVGA/ VGA/ D1 output.z Line base or Frame base operation.z Max. 1024x768 LCD Resolution output.z Texture mapping with anti-aliasing and bilinear interpolation.Sound Process Unit. (SPU)z16 hardware PCM/ADPCM channels.z Built-in dynamic volume compressor.z MP3/WMA decoder.JPEG CODEC.z ISO/IEC 10918-1 baseline JPEG.z High-speed Decoding and Encoding with resolution up to 64MPixel.z Hardware Motion JPEG Decoding and Encoding (up to VGA@30fps) for real-time video record and playback application.MPEG4 decoder.z H.263 baseline profile level30, MPEG4 simple profile level3 Decoder (up to 30 fps @ 640 x 480 resolution).z Build-in de-blocking filter.Face Detection functionz Supports 320x240, 5fpsz Detection multiple faces in a photoOID Binary FunctionMIPI Functionz Up to 450M bit rateVideo-in & CMOS sensor interface and CCIR601/CCIR656standard supported.Embedded 4Mx16 Bits SDRAMStatic memory controller. (NAND FLASH with ECC and 4/8/12/16/24/40/60 -bit BCH)Four-channel DMA controller.Mono and 16 gray levels STN-LCD controller.TFT-LCD controller.z UPS051. (serial RGB)z UPS052. (serial RGB dummy)z Parallel RGB (6-6-6/8-8-8).z I80 (8-bit/16-bit/18-bit system bus) I/F type.z CCIR601/CCIR656.z Scalar engine inside with programmable up-scaling and down-scaling factor.Image Processing Unit.z Histogram statistics for auto brightness and contrast.z Programmable RGB gamma correction.z Color convert matrix for various post-image processing.2-channel DC-DC Boost control circuit for LED Backlight and VGH/VGL voltage generator of TFT-LCD drivers.Interrupt Controller.Universal Serial Bus (USB) 2.0 high/full speed compliance device and USB mini-host with built-in transceiver.Watchdog timer.Six 16-bit timers/counters.2 sets of SD/SDHC/SDIO/MMC card interface.MS/MS pro card interface.xD card interface.2 sets of SPI (master/slave) interface with data rate up to24Mbps.UART (asynchronous serial I/O) or IrDA interface with baud rate up to 1.8432Mbps and 115.2Kbps.81 Programmable general I/O ports (GPIO) with pull-high/lowcontrol.64/88 keys scan controller. Power manager.Built-in 3.3V to 1.2V Regulator. Low voltage reset. 1 data lane MIPIReal-time clock (RTC) with independent power supply. 96MHz, 27MHz and 12MHz PLL.16-bit stereo DAC (2-channel) for audio playback. 12-bit ADC with 6 line-in channels. MIC with PGAC. (program gain control) TV encoder supporting NTSC/PAL and de-flicker and scalar function.3. BLOCK DIAGRAM4. DISCLAIMERThe information appearing in this publication is believed to be accurate.Integrated circuits sold by Generalplus Technology are covered by the warranty and patent indemnification provisions stipulated in the terms of sale only. GENERALPLUS makes no warranty, express, statutory implied or by description regarding the information in this publication or regarding the freedom of the described chip(s) from patent infringement. FURTHERMORE, GENERALPLUS MAKES NO WARRANTY OF MERCHANTABILITY OR FITNESS FOR ANY PURPOSE. GENERALPLUS reserves the right to halt production or alter the specifications and prices at any time without notice. Accordingly, the reader is cautioned to verify that the data sheets and other information in this publication are current before placing orders. Products describedherein are intended for use in normal commercial applications. Applications involving unusual environmental or reliability requirements, e.g. military equipment or medical life support equipment, are specifically not recommended without additional processing by GENERALPLUS for such applications. Please note thatapplication circuits illustrated in this document are for reference purposes only.5. REVISION HISTORY# Description Page Date RevisionNov. 18, 2013 1.0 First edition 6。

1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。

Fuel Performance Efficiency
Target Vehicles: Global A & B segments
Reduced Emissions
10
CONFIDENTIAL INFORMATION
DualTronic™ DT170CT
11
CONFIDENTIAL INFORMATION
PTM®
Part-Time
Open Diff
Ford Explorer Mercury Mountaineer
Cadillac CTS
BMW 330XI Demonstrator
Audi Q7 Ford F-Series Hummer H3
GMC Savana
KIA Borrego Ford Expedition Lincoln Navigator …..and many more Ford Ranger Mazda B-Series Chrysler 300, Dodge Charger Drivetrain TATA Safari, Sumo, Sierra …..and many more Cadillac Escalade GMC Yukon Denali …..and many more Cadillac STS & SRX
• Speeds: Single
• Available reduction ratios:
• 6.54**, 7.17, 8.00, 8.28**, 8.76, 9.07
• Efficiency: >97% (targeted)
• Rated input torque: ~200 Nm continuous (300 Nm peak)
Porsche 911 Turbo
Cadillac CTS
Electronic Shift Transfer Case with BW Controls & ECU: 3.4 Million + produced
(2007 SOP)
GM H2
GM H3
SsangYong Rexton, Musso, Korando
High RPM Concentric Dual Clutch
CONFIDENTIAL INFORMATION
High RPM Parallel Dual Clutch
5
Drivetrain Product Portfolio
Low Pressure Solenoids and Control Systems
12
CONFIDENTIAL INFORMATION
i~Trac™ Front-Wheel Drive AWD Portfolio
Active OnDemand Twin Active On-Demand
ITM 3e™
Drivetrain
NexTrac™
PTM™
T-Trac™
Drivetrain
Dodge Journey
NexTrac™ 100
Key enabler for smaller more fuel efficient AWD
Features • Direct electro-mechanical actuation • Organic primary clutch material • Tunable torque capacity and drag torque • Reduced mass spin loss, rotating inertia Benefits • Optimal vehicle system integration and assembly • Outstanding lifetime NVH performance • Low drag torque and reduced weight enables fuel economy benefits
• Max input speed: ~14,000 rpm • Center distance: 210 mm • Lubrication: Splash • Park lock system
• Electric park pawl actuation (CAN enabled) • Mechanical actuation option
Drivetrain Product Portfolio
DualTronic™ Dual Clutch Modules
Concentric Dual Clutch
Integrated Dual Clutch / Wet Dual Mass Flywheel
High Torque Parallel Dual Clutch
8 CONFIDENTIAL INFORMATION
Drivetrain Product Portfolio
High Pressure Solenoids and Control Systems On-Demand Electro-Hydraulic System
Responsive, efficient, compact: • Solenoid module sub-assembly • High pressure, very low leak solenoids • Proven in 10+ years of AMT use • Hybrid powertrain compatibility • Accumulator pressure supply • Electric pump on demand Dry DCT application launches 2010
14
CONFIDENTIAL INFORMATION
Rear-Wheel Drive AWD Portfolio
Active Torque-On-Demand® Systems
Torque-OnDemand®
Passive Systems
TorqueSensing SpeedSensing
ITM® tc
Drivetrain Product Portfolio
Friction and Clutching Systems
Clutch Modules
Clutch Plates
One-Way Clutches
Brake Bands
CONFIDENTIAL INFORMATION
Torque Converter Clutches 4
Hyundai Santa Fe
Audi A3 Demonstrator
Honda Ridgeline
Kia Sportage
HUATAI (China)
Honda Pilot
Hyundai Tucson Cherry Tiggo
Porsche 911 Turbo
13
CONFIDENTIAL INFORMATION
Step A/T Solenoid Module
CONFIDENTIAL INFORMATION
DCT Control Module
7
Drivetrain Product Portfolio
MDA - Mini Direct-Acting Variable Force Solenoid
Low-Flow VFS for pilot control function Designed to be direct replacement for variable bleed solenoids Reduced leakage and greater accuracy provides improved fuel economy and shift quality
15
CONFIDENTIAL INFORMATION
Electronic Controls: Applications
FWD On-Demand AWD with BW Controls & ECU: 1 Million + produced
(2007 SOP)
Hyundai Santa Fe
Hyundai Tucson
Mahindra Bolero, Scorpio
TATA Safari, Sumo, Sierra
Kia Borrego
16
CONFIDENTIAL INFORMATION
31-03 eGearDrive™
Electric Drive Transaxle
Technical Features
• Mass: 28Kg*
Automatic Transmission Technology
Sห้องสมุดไป่ตู้ep A/T
Friction and Clutching Systems Solenoids and Control Systems
CVT
Friction and Clutching Systems Solenoids and Control Systems
On/Off Solenoids
2-Position Solenoids
PWM Solenoids
Variable Bleed Solenoids (VBS) Proportional Solenoids (Variable Force Solenoids – VFS) Direct-Acting Solenoids (DA VFS)
System Integration
BWUTS DualTronic Modules
Vehicle Integration and Calibration
Transmission Testing and Validation